- Global Hemp Group (GHG) executes first U.S. sublicense relating to Apollon Formularies patents and IP
- The non-exclusive sublicense was issued to Medicinal One for online sales of functional mushroom and hemp-based products
- Global Hemp will receive an in-kind upfront payment and 20 per cent gross revenue on all sales every month
- Global Hemp Group develops environmentally friendly hemp-based products, including construction materials, nanofertilizers and enhanced cannabinoid extraction methods
- Global Hemp (GHG) opened today at $0.01
Global Hemp Group (GHG) has executed its first U.S. sublicense for sales and revenue generation.
It issued the non-exclusive sublicense to Medicinal One for online sales of Apollon-branded hemp and functional mushroom products.
Medicinal One will pay an in-kind upfront payment and 20 per cent of gross revenue on all sales every month.
The global functional mushroom market is projected to hit $23.3 billion by the end of 2030 with a CAGR of over 10 per cent between 2023 and 2030, with North America anticipated to lead the growth due to a surge in the intake of mushrooms as superfoods.
Global Hemp’s manufacturer supplying these products has a long history with hemp-based products and has recently expanded into functional mushroom formulations.
Global Hemp Group develops environmentally friendly hemp-based products, including construction materials, nanofertilizers and enhanced cannabinoid extraction methods.
Global Hemp Group (GHG) opened today at $0.01.
The materials provided in this article are for information only and should not be treated as investment advice. For full disclaimer information, please click here.
